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Original articleDownregulation of IRS-1 in adipose tissue
of offspring of obese mice is programmed
cell-autonomously through
post-transcriptional mechanismsDenise S. Fernandez-Twinn 1,3,*, Maria Z. Alfaradhi 1,3, Malgorzata S. Martin-Gronert 1,
Daniella E. Duque-Guimaraes 1, Ana Piekarz 1, David Ferland-McCollough 2, Martin Bushell 2, Susan E. Ozanne 1ABSTRACTWe determined the effects of maternal diet-induced obesity on offspring adipose tissue insulin signalling and miRNA expression in the aetiology of
insulin resistance in later life. Although body composition and glucose tolerance of 8-week-old male offspring of obese dams were not dysregulated,
serum insulin was signiﬁcantly (po0.05) elevated. Key insulin signalling proteins in adipose tissue were down-regulated, including the insulin
receptor, catalytic (p110β) and regulatory (p85α) subunits of PI3K as well as AKT1 and 2 (all po0.05). The largest reduction observed was in IRS-1
protein (po0.001), which was regulated post-transcriptionally. Concurrently, miR-126, which targets IRS-1, was up-regulated (po0.05). These
two features were maintained in isolated primary pre-adipocytes and differentiated adipocytes in-vitro. We have therefore established that maternal
diet-induced obesity programs adipose tissue insulin resistance. We hypothesise that maintenance of the phenotype in-vitro strongly suggests that
this mechanism is cell autonomous and may drive insulin resistance in later life.
& 2014 The Authors. Published by Elsevier GmbH.
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The prevalence of obesity has been increasing at alarming rates in both
the developed and the developing world [1]. Of particular concern are
the increasing rates of obesity in women of childbearing age [2]. In the
USA the prevalence of obese women aged 20–39 years old tripled
between 1960 and 2000 [3] and in the UK, between 1990 and 2004, the
BMI of pregnant women at their ﬁrst prenatal booking increased by an
average of 1.37 kg/m2 [4]. These statistics have raised concern as
epidemiological studies have revealed a relationship between maternal
obesity and risk of obesity and other features of the metabolic syndrome
in her offspring (reviewed in Alfaradhi and Ozanne [5]). Although the
inheritance of susceptibility genes may contribute to this association,
growing evidence from studies in both humans and animal models
suggests that exposure to an obesogenic environment in utero plays an
important role in mediating this relationship. In humans some of the best
evidence in support of such programmed effects has come from thehttp://dx.doi.org/10.1016/j.molmet.2014.01.007
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bariatric surgery to reduce her weight. These demonstrated a reduced
risk of obesity and other adverse effects in the offspring born after the
surgery compared to those born before surgery [6,7]. These ﬁndings
support the notion that exposure to an obesogenic environment in utero
is able to developmentally programme the offspring physiology. It is
therefore likely that increased maternal obesity during pregnancy is
contributing to the alarming rise in the prevalence of childhood obesity
and type-2 diabetes in the next and subsequent generations.
Animal models strongly support the concept that maternal obesity during
pregnancy can transmit to the offspring, through non-genetic mechan-
isms, an increased risk of obesity, insulin resistance and glucose
intolerance (reviewed in [5]). These include models in non-human
primates [8,9], sheep [10], maternal high fat fed rodents [11–13], and
rodent models employing a cafeteria diet [14,15]. Our recent studies
have focused on a mouse model of maternal diet-induced obesity using
a diet rich in fat and simple sugars that is representative of a westernPI3K, phosphotidylinositol 3-kinase; UTR, untranslated region
ute of Metabolic Science, Level 4, Box 289, Addenbrooke0s Hospital, Cambridge CB2 0QQ, UK
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Original articlehuman diet. Offspring of dams fed this diet throughout pregnancy and
lactation gain excess weight, become obese, insulin resistant and
develop impaired glucose tolerance in adulthood [16]. In addition they
develop non-alcoholic fatty liver disease and demonstrate muscle
mitochondrial dysfunction [17]. These differences are associated with
reduced expression of the insulin receptor (IR), insulin receptor
substrate-1 (IRS-1) and the p85α regulatory subunit of phosphatidyli-
nositol 3-kinase (PI3K) regulatory subunit in the liver [17,18] and
reduced expression of the p110β catalytic subunit of PI3K in skeletal
muscle [19]. However, as these parameters have been measured at a
time point when the animals are obese, it is not clear which of these are
consequences of offspring obesity and which arise as a direct effect of
maternal obesity independently of offspring obesity.
Studies in low birth weight humans and animal models of under-
nutrition have demonstrated that insulin resistance can be a primary
consequence of a suboptimal early environment and can arise
independently of changes in offspring obesity [20–24]. The insulin
resistance is associated with changes in expression of key insulin
signalling proteins [22,23]. In humans and rodents some of the largest
effects on insulin signalling protein expression are observed in adipose
tissue, an organ whose importance in regulation of whole body glucose
homoeostasis has become increasingly apparent in recent years [25–
27]. IRS-1 and PI3K proteins appear to be some of the most vulnerable
to the effects of early under-nutrition [22].
The aim of the current study was to determine whether changes in
insulin sensitivity resulting from maternal diet-induced obesity precede
development of obesity in the offspring and if this was associated with
changes in adipose tissue insulin signalling protein expression. We
further aimed to investigate the potential mechanisms underlying the
programming of insulin signalling protein expression with a focus on
post-transcriptional gene regulation.2. MATERIALS AND METHODS
2.1. Animal model
All studies were approved by the Local Ethics Committee and were
conducted according to the Home Ofﬁce Animals (Scientiﬁc Procedures,
UK) Act 1986. The model has been described in detail previously [18].
Brieﬂy, female C57BL/6J mice, approximately 4 weeks of age were fed ad
libitum either a standard control chow (7% simple sugars, 3% fat [w/w])
RM1 diet or a highly palatable energy-rich obesogenic diet (10% simple
sugars, 20% animal fat [w/w]) and sweetened condensed milk (55% simple
sugar, 8% fat, 8% protein [w/w], Nestle (Nestle, UK) fortiﬁed with mineral
and vitamin mix AIN93G), for 6 weeks before mating for ﬁrst pregnancy.
Both diets were purchased from Special Dietary Services, Witham UK,
compositions of which have been previously described [28]. The dams were
allowed to litter and the ﬁrst litter culled after weaning. This ﬁrst pregnancy
ensured the mice were proven breeders. After a week, mice were re-mated
for a second pregnancy and day 1 of pregnancy was deﬁned by the
appearance of a plug. Dams were maintained on their respective
experimental diets throughout both pregnancies and lactation periods and
were weighed at the beginning and end of pregnancy. Litter sizes were
standardized to 3 males and 3 females on postnatal day 3. Male offspring
only were used in this study. The experimental offspring groups [Control and
Maternal obesity (Mat-Ob); n¼8 liters per group] were weaned onto
standard chow (RM1) at 21 days of age and remained on this diet until the
end of the study. Body weights and food intake was recorded weekly. At
8 weeks of age, following an overnight fast offspring were killed by raising
CO2 concentration. Blood was taken for serum biochemical analyses.326 MOLECULAR METABOLISM 3 (2014) 325–333 & 2014Adipose tissue, liver, vastus lateralis muscle and heart tissue were dissected,
weighed, snap frozen and stored at 80 1C until use.
2.2. Dual-energy X-ray absorptiometry measurement of body
composition
Body composition analysis was performed by dual energy X-ray
absorptiometry (DEXA, Lunar PIXImus densitometer; GE Lunar Corp.,
Madison, WI) on dams at weaning and on offspring at 8 weeks of age
immediately after killing by CO2 asphyxiation.
2.3. Indirect calorimetry
Oxygen consumption (VO2), activity (horizontal, vertical, and ambulating)
and food intake were measured using an Oxymax open-circuit indirect
calorimetry system (Columbus Instruments International, Columbus, OH).
Following a training period the week before, male mice were placed in
calorimeter chambers for 72 h in a light- (12-h light, 12-h dark cycle)
and temperature-controlled environment with free access to standard
chow and water throughout the duration of the 72-h measurement
period. Energy expenditure was recorded as J/min in 2 hourly intervals
and activity data is reported as mean counts of horizontal activity (X-tot),
ambulation (X-amb) and vertical activity (Z-tot). Food intake data is
reported as the average daily intake during calorimetry.
2.4. Plasma analysis
Fasted glucose concentrations were determined in tail blood using a
blood glucose analyser (AlphaTRAK glucose meter, Abbot Logistics B.V.,
Netherlands). Insulin was measured using a Meso Scale Discovery kit
(Gaithersburg, MD, USA). Triglycerides, free fatty acids and cholesterol
were measured using an enzymatic assay (Dade Behring, Siemens
Healthcare). All analyses were carried out on serum collected after an
overnight fast (Core Biochemical Assay Laboratory, Cambridge University
Hospitals NHS Foundation Cambridge, UK).
2.5. Glucose tolerance test (GTT)
Mice were fasted overnight and blood was drawn from the tail for basal
glucose measurements (AlphaTRAK, Abbot Logistics B.V., Netherlands). Mice
were then injected intraperitoneally (i.p.) with 1 g/kg glucose. Further blood
glucose measurements were made at timed intervals. AUC was calculated
by summation of trapezoids (Prism, GraphPad, La Jolla, USA).
2.6. Western blotting
Adipose tissue samples were homogenised in lysis buffer [50 mmol/l
HEPES (pH 8), 150 mmol/l sodium chloride, 1% Triton X100, 1 mmol/l
sodium orthovanadate, 30 mmol/l sodium ﬂuoride, 10 mmol/l sodium
pyrophosphate, 10 mmol/l EDTA and a protease inhibitor cocktail (set III,
Calbiochem Novabiochem Biosciences, Nottingham, UK)] and total
protein concentration was measured using a copper/bicinchoninic assay
(Sigma-Aldrich, UK). Samples (20 mg protein) were subjected to SDS-
PAGE and transferred onto a PVDF membrane (Immobilon-P, Millipore,
Billerica, MA, USA). Following blocking (in 5% non-fat dehydrated milk,
1 TBS, 0.1% Tween 20), the membrane was incubated overnight
with the primary antibody [IRS-1 and PI3K p85α subunit (Upstate
Biotechnology, Millipore, Lake Placid, USA), PI3K p110β subunit, AKT1,
AKT2 and, (Cell Signalling, New England Biolabs, UK); IRβ and protein
kinase C-ζ (PKCζ) (Santa Cruz Biotechnology, Heidelberg, Germany)].
Following washing with TBS/T (1 TBS, 0.1% Tween 20) membranes
were incubated with horseradish peroxidase-conjugated anti-rabbit or
anti-mouse antibody (Jackson ImmunoResearch, Stratech, UK). Antibody
binding was detected using Super Signal West Pico Chemiluminescent
substrate (Thermo Scientiﬁc, UK) and audioradiographed images wereThe Authors. Published by Elsevier GmbH. www.molecularmetabolism.comOpen access under CC BY license.
quantiﬁed using AlphaEase software (AlphaInnotech, San Leandro, USA).
Twenty microgram and 10 mg of a pooled sample was loaded in each
gel and a correct ratio conﬁrmed linearity of signal for each antibody.
2.7. Gene expression
Total RNA was extracted from adipose tissue samples using the
mirVANA miRNA Isolation Kit (Ambion Inc., UK). cDNA was generated
using a High-Capacity cDNA Reverse Transcription Kit (Applied Biosys-
tems, UK) and quantitative real time PCR (qPCR) performed on a
StepOnePlus™ Real-Time PCR System (Applied Biosystems). For SYBR
green assays the primer mix per well consisted of 400 nM primer
(Sigma-Aldrich, UK). For primer sequences see (Supplementary Table 1),
1 SYBR Green master mix (Applied Biosystems, UK) and a 1:10
dilution of sample cDNA. A standard curve was generated using serial
dilution of the pooled cDNA samples. mRNA expression was normalised
to the geomean of selected housekeeping genes from beta-actin,
cyclophilin, PABP1 and HPRT (as stated in ﬁgures). For Taqman assays
(Applied Biosystems, UK) the primer mix per well consisted of 1
Taqman primer (Egﬂ7 assay ID: Mm00618004_m1), 1 Taqman PCR
master mix and 100 ng template cDNA. A standard curve was generated
as above and expression was normalised to beta-actin (Assay ID:
Mm00607939_s1).
2.8. microRNA expression
Total RNA was reversed transcribed using miR-speciﬁc primers (TaqMan
MicroRNA Assays) and Taqman MicroRNA Reverse Transcriptase Kit
(Applied Biosystems, UK) followed by qPCR quantiﬁcation with Taqman
2x Universal PCR Master Mix No AmpErase UNG (Applied Biosystems,
UK). For miR-126, this was hsa-miR-126 Assay ID:002228 (Applied
Biosystems, UK). Standard curves were generated as above and
microRNA expression was normalised to the geomean of housekeepers
including miR-185 (Assay ID: 002271, Applied Biosystems, UK) and U6
snRNA (Assay ID: 001973, Applied Biosystems, UK) as well as sno25,
U5A and sca17 (miScript primer assays, Qiagen, Manchester, UK), none
of which differed between groups.
2.9. Luciferase reporter constructs and assay
Luciferase reporter constructs were generated by cloning the 30-UTR
portion of rat IRS-1 mRNA containing the seed target sequence of miR-
126. PCR on rat white adipose tissue cDNA yielded 1068 of 1086 bp of
mouse 30-UTR. The PCR product was then sub-cloned downstream of
the luciferase gene contained in the pGL3-Basic commercial vector
(Promega, Southampton, UK).
HeLa cells were used for miR-126 over expression studies, and HEK293
cells for miR-126 antagonism studies. Cells were transfected with
100 ng of Fireﬂy-luciferase reporter construct with 10 ng of Renilla-
luciferase pRL-SV40 (Clontech, Basingstoke, UK) as a transfection
control and increasing concentrations of hsa-miR-126 mimic (Life
Technologies, CA, USA) (0, 10, 50 and 100 nM in HeLa) or miR-126
20-O-Methyl antagonist (Sigma-Aldrich, Dorset, England) (0, 10, 50 and
100 nM in HEK293) using RNAi Max transfection agent (Invitrogen,
Paisley, UK). Cells were harvested and the luciferase assay performed
using LAR-II substrate (Promega). Luminescence was detected using the
GloMax system (Promega) and data is presented as a F-Luc signal over
R-Luc signal. The primer sequences for 30UTR cloning of rat IRS-1 were:
Forward primer-CTTAACTGGACGTCACAGGCAGAAT and Reverse primer-
CCGGGGGAAAGGCTTATAGAAGTGG. The 20-O-Methyl rno-miR-126
antagonist sequence used was CGCAUUAUUACUCACGGUACGA, where
every base contained a 20-O-Methyl modiﬁcation.MOLECULAR METABOLISM 3 (2014) 325–333 & 2014 The Authors. Published by Elsevier GmbH. Op2.10. Isolation of primary preadipocytes and differentiation in-vitro
Following killing by carbon dioxide asphyxiation, epididymal fat was
dissected from 8-week-old male mice and collected into fresh Hanks
Basic Salt Solution (HBSS). The tissue was then minced with scissors and
subjected to controlled collagenase digestion in 10 ml of Digestion
solution (15 mg Collagenase Type II, 225 mg bovine serum albumin in
HBSS) (all chemicals from Sigma Aldrich, Poole, UK) with shaking for
30–40 min at 37 1C and 180 rpm till a homogenous digest was obtained.
The solution was then strained through a 100 μm mesh (BD Falcon,
Corning, Tewksbury, USA) and moved to ice for 20 min. The upper white
layer (mature adipocytes) were removed and the next two-thirds of the
digest was taken and mixed with growth medium (High glucose
Dulbecco0s modiﬁed Eagle Medium supplemented with 10% newborn
calf serum, 1% Penicillin-Streptomycin, 200 μM L-glutamine). This
stromal-vascular fraction was then centrifuged twice, resuspending in
growth medium each time. After the ﬁnal spin, cells were counted and
plated at a density of 2 105 per well onto 6 well plates. Cells that were
to be differentiated were supplemented with an adipogenic cocktail of
10 μM insulin (Actrapid) and 150 μM sodium ascorbate, daily for 11 days
(modiﬁed from Shimizu et al. [29]) while undifferentiated cells were
maintained for 11 days in growth medium without adipogenic cocktail.
Cells were harvested on day 11.
2.11. IRS-1 decay following translational block
Primary preadipocytes were cultured for 10 days before treating with
cycloheximide (100 μmol) for 24 h. Cells were then lysed immediately in
lysis buffer (see Section 2.6). Protein concentrations in lysates were
quantiﬁed (BCA kit, Sigma Aldrich, Poole UK), and then standardised to a
common concentration before equal amounts of protein were loaded and
analysed by Western blotting for IRS-1.
2.12. Statistical analysis
Data were analysed from one male per litter hence ‘n’ refers to the
number of litters per group. Data were analysed by ANOVA using Prism
6 (Graphpad, La Jolla, USA). Protein expression data are presented as
percentage mean expression of the control group7SEM. All other data
is shown as mean7SEM. For all data, po0.05 was considered
statistically signiﬁcant.3. RESULTS
3.1. Maternal phenotype
3.1.1. Body composition
Feeding mice an obesogenic diet resulted in signiﬁcantly increased body
weight at the start of pregnancy compared to mice fed a control diet
(32.770.8 g vs. 28.570.4 g; po0.001, n¼6). Dams fed the obeso-
genic diet were also signiﬁcantly heavier than control mothers at the end of
lactation (38.071.1 g vs. 31.170.6 g; po0.05, n¼8). This was
accompanied by increased calorie intake in the obese mothers during
pregnancy (110.8714.0 vs. 65.372.2 kJ per day; po0.05, n¼8) and
lactation (217.676.6 vs. 140.978.0 kJ per day; po
0.0001, n¼8). Body composition of the mothers, assessed by DEXA at
the end of lactation, showed that obese mothers had twice as much total
body fat mass as control dams both in absolute terms and as a percentage
of body weight, while absolute lean mass remained constant (Table 1).
3.1.2. Plasma analysis
Circulating glucose levels in dams at weaning were elevated in the fed
state in obese mothers compared to controls po0.05 (Table 2). Levels327www.molecularmetabolism.comen access under CC BY license.
Control Obese
Lean mass (g) 21.770.7 20.270.9
% Lean mass 75.772.0 56.374.0***
Fat mass (g) 4.870.3 14.172.7***
% Fat mass 18.070.72 39.875.3***
Table 1: Maternal body composition at the end of lactation.
***po0.001.
Fed serum Control Obese
Glucose (mmol/l) 9.470.5 11.7771.04*
Triglycerides (mmol/l) 0.870.1 0.870.1
Free fatty acids (μmol/l) 410.8745.6 796.47130.0*
Cholesterol (mmol/l) 2.170.2 3.870.2***
LDL (mmol/l) 0.970.1 1.170.2
HDL (mmol/l) 1.070.1 1.770.1***
Table 2: Maternal serum metabolites at the end of lactation.
*po0.005.
***po0.001.
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Original articleof free fatty acids (po0.05), total cholesterol (po0.001) and HDL
cholesterol (po0.001) were all signiﬁcantly raised in obese mothers
compared to controls. Triglyceride levels were unchanged.x-tot x-amb z-tot
0
plane of activity
a
Figure 1: Energy expenditure and activity at 8 weeks of age. (A) Energy expenditure of Control
(white circle, solid line) and Mat-Ob (black circle, dashed line) offspring. Mice previously trained
1 week prior to the procedure, were singly housed for a 72 h period in a CLAMS chamber with
free access to both food and water. Parameters of oxygen and carbon dioxide exchange
coupled to food intake enabled quantification of both RER and energy expenditure.
No significant differences determined by repeated measures ANOVA. (B) Physical activity as3.2. Offspring phenotype
3.2.1. Body composition
At 8 weeks of age, offspring of obese dams were a similar weight to
control offspring. Lean mass and fat mass, as assessed by DEXA, were
also similar between the two experimental groups. Bone density was
also comparable at this age (Supplementary Table 2).mean counts of horizontal activity (x-tot), ambulation (x-amb) and vertical activity (z-tot) in the
Control (white bars, n¼6) and Mat-Ob (grey bars, n¼5) groups. No significant differences
determined by a 2-way ANOVA.3.2.2. Metabolic phenotyping
Energy expenditure measured over 72 h was not signiﬁcantly different
between the two experimental groups (Figure 1A). Activity levels were
also not signiﬁcantly different between the two groups (Figure 1B). At
8 weeks of age, glucose tolerance was similar between the two groups
(Figure 2A). However, fasting insulin levels were signiﬁcantly higher in
the offspring of obese mothers compared to controls (Figure 2B).3.2.3. Insulin signalling protein expression in epididymal fat
Protein expression of IRβ was down regulated in epididymal fat of the
Mat-Ob group compared to controls (Figure 3A). Protein levels of
downstream signalling molecules, including the p110β and p85α
subunits of PI3K as well as AKT1 and AKT2 (all po0.05), were also
signiﬁcantly reduced in the Mat-Ob group, whereas levels of PKCζ and
GLUT4 were similar between the two groups (Figure 3A). However, the
biggest difference observed was in IRS-1 that was reduced in the
offspring of the obese dams (po0.001) to less than 10% of control
levels. We also observed a similar reduction in IRS-1 protein levels in the
retroperitoneal fat depot (33716 in the Mat-Ob group vs. 100728 in
the Control group; po0.05, n¼8). However, there were no differences
in IRS-1 mRNA levels either in the epididymal fat depot (0.8970.12 in
the Mat-Ob group vs. 1.0070.11 in the Control group) or the
retroperitoneal fat depot (0.9670.09 in the Mat-Ob group vs.
1.0070.04 in the Control group). In order to test the tissue speciﬁc
effects of the obesogenic maternal diet on IRS-1 protein levels, we also
measured the protein expression of IRS-1 in liver, skeletal muscle and
heart. Protein levels were similar between groups in the liver and heart.
However, there was a signiﬁcant reduction in IRS-1 protein expression in
vastus lateralis in the Mat-Ob group compared to controls (Figure 3B).328 MOLECULAR METABOLISM 3 (2014) 325–333 & 20143.2.4. microRNA (miRNA) expression
As the most marked effect of maternal diet-induced obesity was on
IRS-1 protein expression without changes at the mRNA level, we chose
to examine mechanisms underlying this effect in further detail focusing
on the potential role of miRNAs. A candidate approach was adopted to
investigate differences in miRNAs with complementary binding seed
sequences in the 30UTR of the IRS1 gene. We investigated a panel of
ﬁve miRNAs, which were selected based on bioinfomatic assessment of
their putative binding to the 30UTR of IRS1. Of these ﬁve miRNAs, only
miR-126 was differentially expressed in adipose tissue of the Mat-Ob
group (Figure 4A). Whilst IRS-1 levels in adipose tissue are dramatically
reduced in the Mat-Ob group, miR-126 expression is elevated in
parallel, suggesting that miR-126 can regulate IRS-1 protein expression
in adipose tissue. The miR-126 primary sequence is located within an
intron of Egﬂ7. To determine if Eglf7 mRNA was elevated concomitantly
with miR-126, we measured Egﬂ7 mRNA expression. However expres-
sion of Egﬂ7 was comparable between the two experimental groups
(1.0470.07 in the control group vs. 0.9470.15 in the Mat-Ob group),
which suggests that miR-126 is differentially regulated from its
host gene.
To conﬁrm that miR-126 mediates the repression of IRS1 translation,
the 30-UTR of IRS1 encompassing the miR-126 target site (Figure 4B)
was cloned in a luciferase-based reporter plasmid. The construct was
co-transfected in HeLa cells with increasing concentration of miR-126
mimic. The presence of exogenous miR-126 resulted in a signiﬁcant
reduction in luciferase activity compared to the control (Figure 5A).
Conversely, introduction of a miR-126 antagonist in Hek293 cells
resulted in increased luciferase output of a reporter construct underThe Authors. Published by Elsevier GmbH. www.molecularmetabolism.comOpen access under CC BY license.
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Figure 2: (A) Glucose tolerance following 1 g/kg body weight bolus i.p. glucose injection in
Control (open circles) vs. Mat-Ob (closed circles) offspring; and (B) fasting serum insulin
concentrations in Control (white bars) and Mat-Ob (grey bars) offspring. n¼6 per group.
*¼po0.05 determined by student0s t-test.
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Figure 3: (A) Protein levels of insulin signalling molecules in adipose tissue at 8 weeks of age.
(B) Protein levels of IRS-1 in liver, muscle and heart tissue of 8-week-old males. Signal
intensities were quantified from n¼6 per group, Control (white bars) and Mat-Ob (grey bars)
and data presented as percentage mean expression of the control group7SEM.
*¼po0.05, ***¼po0.001 determined by student0s t-test.
Figure 4: miRNA expression in adipose tissue of 8-week-old male offspring. (A) Expression of
5 candidate miRNAs relative to miR-185 and snRNA U6 housekeepers. (B) IRS-1 protein level
and parallel miR-126 expression in adipose tissue from 8-week old male offspring. (C) Seed
sequence of miR-126 (red) predicted to target the IRS1 30-UTR. n¼8 per group, Control
(white bars) and Mat-Ob (grey bars). * po0.05 determined by Student0s t-test.
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Figure 5: (A) Relative luciferase activity in control (white bars) constructs or constructs
containing the 30 UTR of IRS1 (grey bars) introduced into HeLa cells in the presence of miR-
126 mimic. Firefly luciferase activity for each construct was normalised to the co-transfected
Renilla luciferase construct and then normalised to the change in luciferase in the presence of
miR-126 (normalised luciferase activity in the absence of miR-126 was set to 1). (B) Relative
luciferase activity of the constructs used in (A) in HEK 293 cells upon inhibition of miR-126
with 2-O-Methyl miR-126 antagonist. Normalisation was performed as in (A). ** po0.01,
* po0.05.
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Figure 6: (A) IRS-1 protein levels and (B) miR-126 expression in adipocytes derived from primary cultures of preadipocytes and differentiated for 11 days in-vitro (from n¼4 liters per group,
Control (white bars) and Mat-Ob (grey bars)). ** po0.01 determined by Student0s t-test. (C) Adipocytes derived from primary cultures of preadipocytes [from n¼4 liters per group, Control (open
boxes) and Mat-Ob (closed boxes)] were cultured for 10 days before treatment with cycloheximide. IRS-1 protein was measured by Western blotting and expressed as a percentage of respective
protein levels at time 0.
Original articlethe control of the IRS1 30-UTR (Figure 5B). This data therefore suggests
a direct interaction between miR-126 and its binding site in the 30-UTR
of IRS1.3.2.5. IRS-1 reduction and miR-126 overexpression is retained in
isolated Mat-Ob primary preadipocytes differentiated in-vitro
A reduction in IRS-1 protein levels was observed in Mat-Ob adipocytes
derived from Mat-Ob preadipocytes that had been differentiated in-vitro
compared to controls (Figure 6A). In parallel the increased expression of
miR-126 was also maintained in preadipocytes and differentiated
adipocytes isolated from the Mat-Ob group compared to those isolated
from control offspring (Figure 6B).3.2.6. Maternal obesity does not affect rate of IRS-1 degradation
To directly determine if maternal obesity had any effect on the rate of
IRS-1 protein degradation in-vitro, primary preadipocytes were
cultured for 10 days and then treated with cycloheximide to block
translation. IRS-1 protein levels over time were detected by western
blotting and the rate of protein degradation measured. No difference
in the rate of IRS-1 decay was observed between the two groups
(Figure 6C).330 MOLECULAR METABOLISM 3 (2014) 325–333 & 20144. DISCUSSION
In the current study we investigated animals in young adult life to
dissect out the effects of maternal diet-induced obesity on offspring
insulin resistance that were independent of the increased adiposity
previously observed in older offspring [16]. We showed that at 8 weeks
of age offspring of obese dams have similar body weights and body
composition to the offspring of control-fed dams, as well as a similar
glucose tolerance. However, the offspring of the obese dams were
hyperinsulinaemic, suggesting that they required increased insulin
concentrations to maintain normoglycaemia and were therefore insulin
resistant. This suggests that, as has been shown in low birth weight
humans and rodent models of under-nutrition, maternal over-nutrition
can lead to insulin-resistance in the offspring that is not related to
increased adiposity.
The three key tissues regulating glucose homoeostasis in response to
insulin are the liver, skeletal muscle and the adipose tissue. Although
skeletal muscle has been recognised for many years as the major site of
glucose disposal postprandially, the importance of adipose tissue in
maintaining euglycaemia has become increasingly apparent in recent
years. For example, adipose tissue speciﬁc overexpression of GLUT4
was able to reverse insulin resistance and diabetes in mice selectively
lacking muscle GLUT4 [30]. Furthermore, the fat-speciﬁc ablation of
Rictor – a component of the mTOR complex mTORC2, which catalyses
the phosphorylation of AKT – was found to impair whole body glucoseThe Authors. Published by Elsevier GmbH. www.molecularmetabolism.comOpen access under CC BY license.
and lipid metabolism [31]. The current study demonstrates that maternal
diet-induced obesity leads to impaired adipose tissue insulin signalling
in young mice of obese mothers through reduced IRβ, IRS-1 and the
p110β catalytic and p85α regulatory subunits of PI3K. We postulate that
this contributes to the observed peripheral insulin resistance. It is known
that chronic hyperinsulinaemia exacerbates insulin resistance and
contributes to β-cell failure and ultimately leads to type-2 diabetes
[25]. Insulin resistance in the adipose tissue, leading to increased
demands on pancreatic β-cells to produce insulin could therefore
contribute to the eventual hypoinsulinaemia and impaired glucose
tolerance observed in the offspring of obese dams at 6 months of age.
The greatest reduction in insulin signalling protein levels was observed
in IRS-1 which is well established as lying at the hub of insulin signalling
[32]. Adipose tissue IRS-1 expression is reduced in humans and animals
with type-2 diabetes [33] and in obese subjects [34]. Reduced IRS-1
expression in human and animal adipose tissue impairs downstream
insulin signalling through the PI3K and AKT pathways, resulting in
reduced insulin-stimulated glucose uptake [35]. Acute inhibition of IRS-1
in rats also leads to insulin resistance [36]. It is therefore likely that the
reduction in IRS-1 in the offspring of obese dams observed here
contributes to their development of insulin resistance.
There has been much attention in the programming ﬁeld on the role of
epigenetic mechanisms mediating the relationship between a subopti-
mal early environment and long-term health (reviewed in Barnes and
Ozanne [37] and Galjaard [38]). These have primarily focused on
programmed changes in DNA methylation and histone modiﬁcations in
regulating transcription. However there are other non-genetic/epigenetic
regulatory mechanisms that are operating in programming which are
less well studied. For example, there are increasing instances in which
programmed changes in protein expression are not accompanied by
changes in transcript expression [22,39]. Hence, our observation of
reduced adipose tissue IRS-1 protein levels without a parallel reduction
in IRS1 transcription suggests that the mechanism underlying its altered
expression operates at the post-transcriptional level. Possible mechan-
isms include alterations in IRS-1 protein synthesis or degradation.
Previous studies have shown that the protein levels of IRS-1 may be
regulated by degradation through Ser307 phosphorylation [40]. In
contrast, regulation of IRS-1 synthesis can occur through miRNA-
mediated reductions in translation [41,42] and our ﬁndings support a
role for such a mechanism through binding of miR-126.
MicroRNAs are short non-coding RNA molecules which function by
binding speciﬁc sequences within the 30 untranslated region of target
mRNAs and repressing mRNA translation [43]. Numerous miRNAs have
been associated with obesity, insulin resistance and type-2 diabetes
[44,45]. However to date, only a very limited number of studies have
identiﬁed miRNAs as being involved in developmental programming. In
the offspring of high fat diet fed dams, hepatic miRNAs whose predicted
targets were proteins important for epigenetic regulation such as
methylCpG binding domain proteins are differentially expressed [46].
More recently, we demonstrated that miR-483 expression was
increased in both rodents and humans in response to a suboptimal
early nutrition and intrauterine growth restriction leading to a reduction
in adipocyte expandability [39].
In the current study, we describe a novel observation that maternal diet-
induced obesity leads to an increased expression of miR-126 in adipose
tissue. While miR-126 has been shown previously to directly regulate
IRS-1 translation in hepatocytes [42] and in HEK293 and MCF7 breast
cancer cells [41], we have shown for the ﬁrst time that IRS-1 is a
potential target of miR-126 in adipose tissue. A programmed increase in
miR-126 in response to maternal diet-induced obesity therefore providesMOLECULAR METABOLISM 3 (2014) 325–333 & 2014 The Authors. Published by Elsevier GmbH. Opone mechanism by which IRS-1 may be silenced at the translational
level. Although some studies show miR-126 to be co-regulated with its
host gene Egﬂ7, miR-126 expression did not parallel that of Egﬂ7 in
adipose tissue in the current study. This could mean that they are
independently regulated by maternal diet-induced obesity, either through
the use of different promoters or through differences in stability.
Crucially, we showed that the programmed loss of IRS-1 protein and
increase in miR-126 in adipose tissue resulting from maternal diet-
induced obesity is maintained in primary adipocyte precursors isolated
from epididymal fat from 8-week-old offspring, which were then
expanded in culture and then differentiated into adipocytes. To conﬁrm
that the loss of IRS-1 was not driven by increased degradation, we
applied a translational block in primary preadipocytes by treating with
cycloheximide and showed that rate of IRS-1 decay was not affected by
maternal diet-induced obesity. This suggests that the loss of IRS-1 is not
driven by proteosomal degradation, and that it results from decreased
protein synthesis, consistent with the observed increase in miR-126.
The maintenance of the programmed phenotype (i.e. decreased IRS-1
and increased miR-126 in isolated preadipocytes differentiated in vitro)
strongly suggests that the mechanism is cell autonomous and is
retained following multiple rounds of cell division.
In conclusion, we have demonstrated that maternal diet-induced obesity
leads to offspring insulin resistance prior to development of obesity. This is
associated with reductions in key adipose tissue insulin signalling proteins
including IRS-1 that is programmed at the translational level. These ﬁndings
provide a mechanism by which maternal diet-induced obesity leads to
increased risk of type-2 diabetes in the offspring. The adipose tissue insulin
signalling proteins inﬂuenced by maternal obesity are very similar to those
differentially expressed in low birth weight humans and animal models of
foetal under-nutrition. This suggests that in response to a wide range of
suboptimal early environmental conditions, common pathways are initiated
which ultimately lead to increased risk of type-2 diabetes.FUNDING
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